Last reviewed · How we verify
NCT05014113
H-28 DELTA ST-C and Minima Retrospective Study.
trial testing DELTA-ST cup in combination with MINIMA stem in Osteoarthritis, Hip in 95 participants. Status unknown.
31 March 2022
Quick facts
| Lead sponsor | Limacorporate S.p.a |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 95 |
| Start date | 15 September 2020 |
| Primary completion | 31 March 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- DELTA-ST cup in combination with MINIMA stem
Conditions studied
- Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →
Sponsor
Limacorporate S.p.a
Who can join
18 and older, any sex, with Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to assess the clinical and radiographic outcomes of DELTA ST-C in combination with MINIMA stem at 3 years after primary THA surgery, and to evaluate the overall survivorship of the implant.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Early Clinical and Radiographic Outcomes of Total Hip Arthroplasty with DELTA ST-C Cup and MINIMA S Stem.
Christodoulou N, Volonakis E, Voutsas K, Raptis K, et al · · 2023 · cited 6× · PMID 36984608 · DOI 10.3390/medicina59030607
Verify or expand the search:
- PubMed search for NCT05014113
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis, Hip
Currently open trials in the same condition.
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT06578182 — The Effect of ColcHicine on the Incidence of Knee or Hip Replacements · Phase 3 · recruiting
- NCT06342843 — Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty (SPLAsH) · NA · recruiting
- NCT06249958 — Transforming Rehabilitation: Personalised Care for a Better Quality of Life · recruiting
- NCT05700682 — Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee · recruiting
Other Limacorporate S.p.a trials
Trials by the same sponsor.
- NCT05180071 — A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA · NA · not yet recruiting
- NCT05606120 — H-35 CL TRAUMA Cemented Femoral Stem · completed
- NCT05007067 — H-29 DELTA Multihole TT Study. · terminated
- NCT06870123 — Randomized MINIMA Stem with DELTA TT or DELTA ST-C · NA · active not recruiting
- NCT04884542 — Multigen Plus H Study and AMF TT Cones · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05014113 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Limacorporate S.p.a
- Last refreshed: 20 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05014113.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing